MRI characterization of residual mediastinal masses in Hodgkin's disease: Long-term follow-up

Magnetic Resonance Imaging

Volumn 22, Issue 1, 2004, Pages 31-38

  Di Cesare, Ernesto ^a   Cerone, Gabriella ^a   Enrici, Riccardo Maurizi ^b   Tombolini, Vincenzo ^a   Anselmo, Paola ^b   Masciocchi, Carlo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Hodgkin disease; Lymphoma; Magnetic resonance; MR; Tissue characterization

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DOXORUBICIN; GADOLINIUM; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INFLAMMATION; MALE; MEDIASTINUM MASS; MINIMAL RESIDUAL DISEASE; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 1242269938     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2003.08.002     Document Type: Article

References (23)

1. Castellino R.A. Hodgkin's disease practical concepts for the diagnostic radiologist . Radiology. 159:1986;305-310.
2. Tesoro-Tess J.D., Balzarini L., Ceglia E., et al. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non-Hodgkin lymphoma. Eur J Radiol. 12:1991;81-90.
3. Skillings J.L., Bramwell V., Nicholson R.L., et al. A prospective study of magnetic resonance imaging in lymphoma staging. Cancer. 67:1991;1838-1843.
4. Canini R., Battista G., Monetti N., et al. I linfomi bulky con localizzazione mediastinica ruolo della risonanza magnetica e della SPECT-67Ga nella valutazione delle masse residue . La Radiologia Medica. 90:1995;448-456.
5. Mendenhall N.P. Diagnostic procedure, and giudelines for the evaluation, and follow-up of Hodgkin's disease. Semin Radiation Oncol. 6:1996;131-145.
6. Davini O., Levis A., Garabello D., et al. La risonanza magnetica nello studio delle masse mediastiniche residue dopo terapia nei linfomi. La Radiologia Medica. 83:1992;230-236.
7. Nyman R.S., Forsgren G., Glimelius B. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging. Acta Radiologica. 37:1996;323-326.
8. 67Ga-scintigraphy for the imaging of residual lymphoma. Haematologica. 80:1995;569-571.
9. Chen J.L., Osborne B.M., Bitler J.J. Residual fibrous masses in treated Hodgkin's disease. Cancer. 60:1987;407-413.
10. Drace J., Carlsen S., Chang P. MR imaging strategies for differentiating benign residual versus active or recurrent tissue in lymphoma. Radiology. 173:1989;273.
11. Martman M. Mediastinal fibrosis simulating residual Hodgkin's disease. Am J Med Sci. 287:1984;40-42.
12. Nyman R.S., Rehn S.M., Glimelius B.L., et al. Magnetic resonance imaging for assessment of treatment effects in mediastinal Hodgkin's disease. Acta Radiologica. 28:1987;145-151.
13. 67Ga. La Radiologia Medica. 90:1995;797-803.
14. Rahmouni A., Tempany C., Jones R., et al. Lymphoma monitoring tumor size and signal intensity with MR imaging . Radiology. 188:1993;445-451.
15. Gasparini M.D., Balzarini L., Castellani M.R., et al. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma. Cancer. 72:1993;577-582.
16. Glazer S.H., Lee J.K.T., Levit R.G. Radiation fibrosis differentiation from recurrent tumor by MRI . Radiology. 156:1985;721-726.
17. Lee J.K.T., Glazer H.S. Controversy in the MR imaging appearance of fibrosis. Radiology. 191:1990;263-267.
18. Negendank W.G., Al-Katib A.M., Karanes C., et al. Lymphomas MR imaging contrast characteristics with clinical-pathologic correlations . Radiology. 177:1990;209-216.
19. Stroszczynski C., Hosten N., Oellinger J., et al. Malignant lymphoma magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions . Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 171:1999;192-199.
20. 67Ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma a prospective pilot study . MAGMA. 4:1996;213-224.
21. 67Ga scan in mediastinal malignant lymphoma a prospective pilot study . Ann Oncol. 5:1994;433-436.
22. Rahmouni A., Divine M., Lepage E., et al. Mediastinal lymphoma quantitative changes in gadolinium enhancement at MR imaging after treatment . Radiology. 219:2001;621-628.
23. Forsgren G., Nyman R., Glimelius B., et al. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease. Acta Radiologica. 35:1994;564-569.